XYT-20144-20655
3 vaccinations
8 coded responses
40 check-ins
8 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 903 / CA
- Registered
- 2021-03-05
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-05
Registered in v-safe
-
2021-03-05
Dose 1 — Moderna
-
2021-03-05
Survey response — 0 day, dose 1MedDRA: No adverse event — Feeling: Fair · Site: Pain, ItchingMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-03-06
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-07
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-03-08
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Swelling · Fatigue or tirednessAdult check-in
- 2021-03-09
- 2021-03-10
- 2021-03-11
- 2021-03-12
-
2021-03-19
Survey response — 14 day, dose 1MedDRA: Injection site discolouration, Injection site erythema, Injection site rash, Injection site swelling — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-03-26
-
2021-04-01
Dose 2 — Moderna
- 2021-04-01
-
2021-04-02
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationAdult check-in
-
2021-04-02
Report sent to call center — days 1–6 daily, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Fatigue or tiredness, NauseaAdult check-in
- 2021-04-04
- 2021-04-05
-
2021-04-06
Survey response — days 1–6 daily, dose 2MedDRA: Injection site rash — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-08
Survey response — 7 day, dose 2MedDRA: Injection site rash — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-04-15
-
2021-04-22
Survey response — 21 day, dose 2MedDRA: Injection site pruritus, Injection site warmth, Pruritus — Feeling: FairMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-05-01
Survey response — 28 day, dose 2MedDRA: Asthma, Pre-existing disease, Throat tightness — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-05-01
Report sent to call center — 28 day, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-05-06
Survey response — 35 day, dose 2MedDRA: Dyspnoea, Wheezing — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-05-06
Report sent to call center — 35 day, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-13
-
2021-06-17
Call successfulCompleted over the phone
- 2021-07-01
- 2021-09-30
-
2022-01-14
Dose 3 — Moderna
-
2022-01-14
Health check-in — 0 day, dose 3Feeling: Poor · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-15
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-01-16
Survey response — days 1–6 daily, dose 3MedDRA: Cough, Wheezing — Feeling: Poor · Site: Swelling · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
-
2022-01-17
Health check-in — days 1–6 daily, dose 3Feeling: Poor · Fever · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-01-18
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-01-19
- 2022-01-20
- 2022-01-21
- 2022-01-30
- 2022-02-04
- 2022-02-11
- 2022-02-18
- 2022-02-25
- 2022-04-15
- 2022-07-17
- 2023-01-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-05 | Moderna | |
| 2 | 2021-04-01 | Moderna | |
| 3 | 2022-01-14 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-04-02 | Successful | Completed over the phone |
| 2021-05-01 | Successful | Completed over the phone |
| 2021-05-06 | Successful 2021-06-17 |
Completed over the phone |
Free text
Release 5
Systemic reaction (other): No
Symptoms: The injection site developed a red raised rash about the size of a small peach, and now the rash is gone but it left dark colored skin in the shape of the rash
Release 7
Systemic reaction (other): Rash on the injection site
Systemic reaction (other): Rash at injection
Symptoms: Injection site itches on both arms and sometimes becomes warm
Release 8
Symptoms: Esophagus begin to close i was started on advere steroid inhaler and albuterol inhaler and i dont have asthma
Symptoms: Wheezing shortness of breath
Release 10
Systemic reaction (other): Wheezing coughing
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | ✓ | ✓ | ✓ |
| SD | Dyspnoea | ✓ | ✓ | ✓ |
| SD | Injection site discolouration | ✓ | ✓ | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Pruritus | ✓ | ✓ | ✓ |
| SD | Throat tightness | ✓ | ✓ | ✓ |
| SD | Wheezing | ✓ | ✓ | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Injection site rash | ✓ | ✓ | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
| SRO | Wheezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release